Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q4 2021 (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $114,610 (100.0% shares, 0.0% debt)

Holdings (10)

— MERUS N V 21.7%

Value ($000) $24,912 Shares 783,398 Est. Cost $31.80 Unrealized —

TVTX TRAVERE THERAPEUTICS INC 20.0%

Value ($000) $22,878 Shares 737,061 Est. Cost $28.16 Unrealized 0.0%

— ALPINE IMMUNE SCIENCES INC 15.2%

Value ($000) $17,478 Shares 1,261,927 Est. Cost $13.85 Unrealized —

— BELLUS HEALTH INC NEW 14.1%

Value ($000) $16,125 Shares 2,003,114 Est. Cost $8.05 Unrealized —

— IMMUNOGEN INC 13.8%

Value ($000) $15,801 Shares 2,129,531 Est. Cost $7.42 Unrealized —

— PARDES BIOSCIENCES INC 5.7%

Value ($000) $6,574 Shares 401,593 Est. Cost $16.37 Unrealized —

— THESEUS PHARMACEUTICALS INC 4.5%

Value ($000) $5,191 Shares 409,358 Est. Cost $12.68 Unrealized —

— CYMABAY THERAPEUTICS INC 3.6%

Value ($000) $4,140 Shares 1,224,968 Est. Cost $3.38 Unrealized —

— PIERIS PHARMACEUTICALS INC 1.3%

Value ($000) $1,449 Shares 383,266 Est. Cost $3.78 Unrealized —

— OTONOMY INC 0.1%

Value ($000) $62 Shares 30,000 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	783,398	$24,912	21.7%	$31.80	—	COM	N5749R100
TVTX	TRAVERE THERAPEUTICS INC	737,061	$22,878	20.0%	$28.16	0.0%	COM	89422G107
—	ALPINE IMMUNE SCIENCES INC	1,261,927	$17,478	15.2%	$13.85	—	COM	02083G100
—	BELLUS HEALTH INC NEW	2,003,114	$16,125	14.1%	$8.05	—	COM NEW	07987C204
—	IMMUNOGEN INC	2,129,531	$15,801	13.8%	$7.42	—	COM	45253H101
—	PARDES BIOSCIENCES INC	401,593	$6,574	5.7%	$16.37	—	COM	69945Q105
—	THESEUS PHARMACEUTICALS INC	409,358	$5,191	4.5%	$12.68	—	COM	88369M101
—	CYMABAY THERAPEUTICS INC	1,224,968	$4,140	3.6%	$3.38	—	COM	23257D103
—	PIERIS PHARMACEUTICALS INC	383,266	$1,449	1.3%	$3.78	—	COM	720795103
—	OTONOMY INC	30,000	$62	0.1%	$2.07	—	COM	68906L105